{
  "trial_id": "NCT00674596",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "CKD stage 1 patients",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Older than 18 years of age",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Type 2 Diabetic patients",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Proteinuria",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Ischemic ST-T alterations and voltage criteria for LVH on electrocardiogram",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "History of revascularization or myocardial infarction",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Elevated liver enzymes (AST or ALT levels \u2265 40U/L)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Renal failure (serum creatinine levels > 1.3 mg/dl)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has type 1 diabetes, cardiomyopathy, and is taking ACE inhibitors and Beta blockers.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT00674596",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}